Journal of the Korean Society of Food Science and Nutrition (한국식품영양과학회지)

The Korean Society of Food Science and Nutrition (한국식품영양과학회)
권호 표지
DOI QR코드

DOI QR Code

Effects of β3-Adrenergic Receptor Polymorphism on the Hyperglycemia in Korean Subjects

베타 3-아드레날린 수용체의 유전자형이 고혈당증 유발에 미치는 영향

  • 오현희 (한국한의학연구원 의료연구부) ;
  • 최선미 (한국한의학연구원 의료연구부) ;
  • 양현성 (한국한의학연구원 의료연구부) ;
  • 김길수 (기린한방병원) ;
  • 윤유식 (한국한의학연구원 의료연구부)
  • Published : 2004.01.01
Download PDF
⟨ Previous Next ⟩

Abstract

This study was conducted to examine the effects of $\beta$3-adrenergic receptor polymorphism on the blood glucose level and obesity in 530 volunteers, who attended a weight loss program in a local obesity clinic. The age differences in total subjects and the distribution of male and female were 26.55$\pm$0.31 yr, 9.1% (n=48), 90.9% (n=492). The genotype distribution of $\beta$3-AR gene polymorphism were WW type 75%, WR type 22% and RR type 3%. Among many parameters, fasting blood glucose was significantly higher in WR＋RR type (p=0.001) compared with WW type. When the subjects were divided into two groups by 6.105 mmol/L of the fasting blood glucose level, the frequency of hyperglycemia was 23.3% in WW type subjects, while there was a increase to 35.6% in WR＋RR type subjects (p=0.011, $\chi$$^2$-analysis). When hyperglycemia group was compared with normoglycemia group, obesity index (p=0.044), %body fat (p=0.046) and TG (p=0.000) were significantly higher, and HDL (p=0.006) was significantly lower in the hyperglycemia. When all of the above factors were included in stepwise logistic regression analysis to find risk factors of hyperglycemia, the results were that the odds ratio for hyperglycemia were 2.015 (p=0.011) for WR+RR type of $\beta$3-AR gene, 2.165 (p=0.000) for TG and 0.419 (p=0.059) for HDL cholesterol. There was a significantly positive correlation between the blood glucose vs BMI, WHR, body fat in the WW type (r=0.099, 0.119, 0.082) However, in the WR and RR type there were no significance between the blood glucose vs BMI, WHR, body fat. These data suggest that the WR＋RR genotype of $\beta$3-AR has a very strong association with increased blood glucose level and might be a significant risk factor for hyperglycemia among Korean subjects.

한국인 남녀 530명을 대상으로 $\beta$3-AR의 유전자 다형성이 비만과 혈당의 증가에 미치는 영향을 연구한 결과 연구대상자들의 평균 연령은 26.55$\pm$0.31세이었고, 남성이 9.1%,여성이 90.9%이었다. $\beta$3-AR의 유전자 다형성의 분포는 WW형 0.75, WR형 0.22, RR형 0.03이었고, BMI 25 kg/$m^2$를 기준으로 하여 정상군에서 WW, WR, RR형의 빈도수는 각각0.75, 0.23, 0.02이었고, 비만군에서는 각각 0.76, 0.21, 0.03이었다. 유전자 다형성에 따라 혈당은 WR＋RR형에서 WW형에 비해 유의적으로 증가하였다(p=0.001). 혈당 6.105 mmol/L을 기준으로 $\beta$3-AR의 유전자 다형성의 빈도수를 분석한 결과 WR＋RR형의 빈도수가 고혈당군에서는 35.6%이었고 정상혈당군에서는 23.3%으로 변이형의 빈도가 고혈당군에서 유의적으로 높았다(p=0.011). 혈당에 따라 비만도와 체지방율은 고혈당군에서 유의적으로 증가하였다(p=0.044, 0.046). HDL 콜레스테롤은 정상혈당군에서 유의적으로 증가하였고(p=0.006), 중성지방은 고혈당군에서 유의적으로 증가하였다(p=0.000). 혈당의 증가에 가장 영향을 미치는 지표를 분석하기 위해 다단계 로지스틱 회귀분석한 결과 중성지방(p=0.000), 혈중 알부민(p=0.008), $\beta$3-AR의 유전자 다형성 (p=0.011), HDL 콜레스테롤(p=0.059) 순으로 나타났다. 특히 중성지방의 증가와 $\beta$3-AR의 유전자의 WR＋RR형은 고혈당의 유발 위험율을 각각 2.165배, 2.015배 증가시키고, HDL 콜레스테롤의 증가는 위험율을 0.491배 감소시키는 결과를 보인다. 각각의 유전자다형성 군에서 혈당과 BMI, WHR, 체지방량의 상관성을 분석한 결과에서 정상군에서는 비만의 판정지표인 BMI, WHR, 체지방량과 혈당이 유의적인 정의 상관관계를 나타내었으나 변이형인 WR, RR형에서는 이들 변수간에 상관성이 보이지 않았다 결과적으로 $\beta$3-AR 유전자의 변이형에서 혈당은 증가하였고, 고혈당에서는 체지방 및 중성지방이 증가하였고, HDL 콜레스테롤은 감소하였다. 또한 고혈당과 변이형의 빈도는 유의적인 상관성을 나타내었다. 따라서 $\beta$3-AR 유전자의 변이형은 혈당과 혈중 지질의 조성변화에 영향을 미치며 이는 고혈당의 위험성을 예견할 수 있는 독립적인 지표로 나타났다.

Keywords

References

  1. Diabetes v.41 Visceral obesity in men. Associations with glucose tolerence, plasma insulin, and lipoprotein levels. Pouliot,M.C.;Despres,J.P.;Nadeau,A.;Moorjani,S.;Prud'Homme,D.;Lupien,P.J.;Tremblay,A.;Bouchard,C. https://doi.org/10.2337/diabetes.41.7.826
  2. N Engl J Med v.321 Early metabolic defects in person at increased risk for non-insulin dependent diabetes mellitus. Eriksson,J.;Franssila-Kallunki A.;Ekstrand,A.;Saloranta,C.;Widen,E.;Schalin,C.;Groop,L. https://doi.org/10.1056/NEJM198908103210601
  3. Science v.259 Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Hotamisligil,G.S.;Shargill,N.S.;Spiegelman,B.M. https://doi.org/10.1126/science.7678183
  4. Science v.245 Molecular characterization of the human β3-adrenergic receptor. Emorine,L.J.;Marulio,S.;Briend-Sutren,M.M.;Patey,G.;Tate,K.;Delavier-Klutchko,C.;Strosberg,A.D. https://doi.org/10.1126/science.2570461
  5. Br J Clin Pharmacol v.48 Population frequency, mutation linkage and analytical methodology for the Arg16Gly, Gln27Glu and Thr16Ile Polymorphism in the beta-3 adrenero recepotr among Turks. Aynacioglu,A.S.;Cascorbi,I.;Gungor,K.;Ozkur,M.;Bekir,N.;Roots,I.;Brockmoller,J. https://doi.org/10.1046/j.1365-2125.1999.00082.x
  6. Biochem Biophys Res Commun v.15 A mutation in the β3-adrenergic receptor gene is associated with obesity and hyperinsulinemia in Japanese subjects. Kadowaki,H.;Yasuda,K.;Iwamoto,K.;Otabe,S.;Shimokawa,K.;Silver,K.;Walston,J.;Yoshinaga,H.;Kosaka,K.;Yamada,N.
  7. Clin Chim Acta v.274 Association of the Trp64Arg mutation of the β3-adrenergic receptor with fatty liver and mild glucose intolerance in Japanese subjects. Shima,Y.;Tsukada,T.;Nakanishi,K.;Ohta,H. https://doi.org/10.1016/S0009-8981(98)00059-X
  8. N Engl J Med v.333 Time of onset of noninsulin-dependent diabetes mellitus and genetic variation in β3-adrenergic receptor gene. Walston,J.;Silver,K.;Bogardus,C.;Knowler,W.C.;Celi,F.S.;Austin,S.;Manning,B.;Strosherg,A.D.;Stem,M.P.;Raben,N.;Sorkin,J.D.;Roth,J.;Shuldiner,A.R. https://doi.org/10.1056/NEJM199508103330603
  9. J Clin Invest v.101 A paired sibling analysis of the beta-3 adrenergic receptor and obesity in Mexican Americans. Mitchell,B.D.;Blangero,J.;Comuzzie,A.G.;Almasy,L.A.;Shuldiner,A.R.;Silver,K.;Stem,M.P.;MacCluer,J.W.;Hixson,J.E. https://doi.org/10.1172/JCI512
  10. Clin Exp Pharmacol Physiol v.24 Expression of the β3-adrenoreceptor gene polymorphism (Trp64Arg) in obese diabetic and non-diabetic subjects. Jeyasingam,C.L.;Bryson,J.M.;Caterson,I.D.;Yue,D.K.;Donnelly,R. https://doi.org/10.1111/j.1440-1681.1997.tb02122.x
  11. J Clin Endocrinol Metab v.64 Trp64Arg polymorphism of the β3-adrenergic receptor gene in pregnancy; association with mild gestational diabetes mellitus. Festa,A.;Krugluger,W.;Shnawa,N.;Hopmeier,P.;Haffner,S.M.;Schernthaner,G.
  12. J Clin Endocrinol Metab v.83 The Trp64Arg polymorphism of the β3-adrenergic receptor gene is not associated with obesity or type 2 diabetes mellitus in a large population-based caucasian cohort. Buettner,R.;Schaffler,A.;Arndt,H.;Rogler,G.;Nusser,J.;Zietz,B.;Enger,I.;Hugl,S.;Cuk,A.;Scholmerich,J.;Palitzsch,K.D. https://doi.org/10.1210/jc.83.8.2892
  13. Diabetes v.48 Polymorphism of the human β3-adrenoceptor gene forms a well-conserved haplotype that is associated with moderate obesity and altered receptor function. Hoffstedt,J.;Poirier,O.;Thorne,A.;Lonnqvist,F.;Herrmann,S.M.;Cambien,F.;Arner,P. https://doi.org/10.2337/diabetes.48.1.203
  14. Diabetologia v.40 β3-adrenergic-receptor polymorphism: a genetic marker for visceral fat obesity and the insulin resistance syndrome. Sakane,N.;Yoshida,T.;Umekawa,T.;Kondo,M.;Sakal,Y.;Takahashi,T. https://doi.org/10.1007/s001250050663
  15. Indicator of Clinical Pathology(8 ed.) Seoul National University Hospital
  16. Am J Clin Nutr v.46 Methods for the assessment of human body composition: Traditional View. Lukaski,H.C.
  17. J Korean Diet Assoc v.22 The significance of the β3-adrenergic receptor gene polymor phism in obese Koreans. Kim,B.J.;Kim,S.H.;Kim,D.J.;Hahm,J.R.;Kim,J.S.;Ahn,K.J.;Chung,J.H.;Min,Y.K.;Lee,M.S.;Lee,M.K.;Kim,K.W.
  18. Int J Obes Relat Metab Disord v.20 Polymorphisms of uncoupling protein(UCP) and beta 3-adrenoreceptor genes in obese people submitted to a low calorie diet. Fumeron,F.;Durack-Bown I.;Betoulle,D.;Cassard-Doulcier,A.M.;Tuzet,S.;Bouillaud,F.;Melchior,J.C.;Ricquier,D.;Apfelbaum,M.
  19. Intern J Obes v.20 Polymorphism of the β3-adrenergic receptor gene in morbid obesity. Oksanen,L.;Mustajoki,P.;Kaprio,J.;Kainulatnen,K.;Janne,O.;Kontula,K.
  20. J Korean Soc Study Obes v.6 β3-adrenoreceptor and uncoupling protein gene polymorphism and weigh loss in obese control program. Chang,S.P.;Woo,J.T.;Kim,Y.S.;Choi,Y.K.;Shin,H.D.;Paeng,J.R.
  21. J Korean Diet Assoc v.23 Association between uncoupling protein-1 and 3-adrenergic reveptor gene polymorphisms and energy metabolism in normal Korean adults. Kim,J.H.;Yun,S.K.;Kim,C.H.;Byun,D.W.;Kim,Y.S.;Suh,K.I.;Yoo,M.H.
  22. Diabetes v.45 Insulin sensitivity and body weight changes in young white carriers of the codon 64 amino acid polymorphism of the β3-adrenergic receptor gene. Urhammer,S.A.;Clausen,J.O.;Hansen,T.;Pedersen,O. https://doi.org/10.2337/diabetes.45.8.1115
  23. N Engl J Med v.333 Association of a polymorphism in the β3-adrenergic receptor gene with features of the insulin resistance syndrome in Finns. Widen,E.;Lehto,M.;Kanninen,T.;Walston,J.;Shuldiner,A.R.;Groom,L.C. https://doi.org/10.1056/NEJM199508103330604
  24. Diabetologia v.41 Synergistic effect of polymorphism in uncoupling protein 1 and β3-adrenergic receptor genes on basal metabolic rate in obese Finns. Valve,R.;Heikkinen,S.;Rissanen,A.;Laakso,M.;Unsitupa,M. https://doi.org/10.1007/s001250050915
  25. Korean Soc Endocrin v.17 Associations of polymorphism in uncoupling protein 2 and β3-adrenergic receptor with obesity in Korean adults Lee,H.J.;Park,H.Y.;Sung,Y.A.;Hong,Y.S.
  26. Int J Obes Relat Metab Disord v.24 The Trp64Arg polymorphism of the β3-adrenergic receptor gene and obesity in Chinese subjects with components of the metabolic syndrome. Thomas,G.N.;Tomlinson,B.;Chan,J.C.;Young,R.P.;Critchley,J.A. https://doi.org/10.1038/sj.ijo.0801193
  27. Korean Soc Endocrin v.13 Effects of β3-adrenergic receptor gene mutation on the body fat distribution and weight loss in obese subjects. Park,S.W.;Lee,H.C.;Kown,S.J.;Cho,E.Y.;Lee,J.H.;Song,Y.D.;Lim,S.K.;Kim,K.R.;Hub,K.B.
  28. Korean Assoc Internal Medicine v.53 Significance of β3-adrenergic receptor gene polymorphism in the pathogenesis of NIDDM in Koreans. Ahn,K.J.;Kim,K.A.;Kim,Y.S.;Choung,J.H.;Koh,E.M.;Min,Y.K.;Lee,M.S.;Lee,M.K.;Kim,J.W.;Kim,K.W.;Kim,S.W.;Uang,I.M.;Kim,Y.S.;Chang,R.;Choi,Y.K.